Male Infertility Market Size (2024 - 2029)

The male infertility market is projected to experience growth due to several factors, including the increasing incidence of infertility and advancements in assisted reproductive technology. The market's expansion is influenced by the rising awareness and adoption of infertility testing and treatments, driven by lifestyle factors such as stress, obesity, smoking, and alcohol consumption. Technological advancements in assisted reproductive technologies are particularly significant, offering effective solutions for male infertility issues like abnormal sperm quality and low sperm count. Despite these growth drivers, the high cost of treatments may pose a challenge to market expansion.

Market Size of Male Infertility Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Male Infertility Market Summary
Study Period 2021 - 2029
Market Size (2024) USD 3.85 Billion
Market Size (2029) USD 4.58 Billion
CAGR (2024 - 2029) 3.54 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Male Infertility Market Major Players

*Disclaimer: Major Players sorted in no particular order

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Male Infertility Market Analysis

The Male Infertility Market size is estimated at USD 3.85 billion in 2024, and is expected to reach USD 4.58 billion by 2029, growing at a CAGR of 3.54% during the forecast period (2024-2029).

Covid-19 has significantly impacted market growth during the pandemic due to the effect of disease on sperm concentration and motility. This might have led to increased adoption of infertility testing during the pandemic to diagnose the address infertility issues. For instance, according to the study published in 'Medicine Journal' in July 2022, following a COVID-19 infection, male fertility may be affected for 72 to 90 days as a result of a considerable decline in sperm concentration and motility. There is strong proof that fever can impact spermatogenesis. Such instances might have positively impacted the market growth during the pandemic due to reduced spermatogenesis and the decline in the motility of sperm. Furthermore, post-pandemic, the market is expected to show significant growth due to a rise in male infertility and technological advancements in infertility testing, among others.

The growth of the male infertility market is attributed to the increasing incidence of infertility, high adoption of assisted reproductive technology (ART), and technological advancement in ART, among others. Moreover, rising stress levels, obesity, smoking, and consumption of alcohol is also some of the factors that are contributing to infertility in male. Furthermore, growing awareness, increasing R&D expenditure, and changing lifestyles are also fueling the male infertility market. According to the study published in the Asian Pacific Journal of Reproduction in October 2021, around 9% of couples worldwide experience reproductive issues, of which nearly 50% are caused by male factor infertility. Furthermore, according to the Newcastle University press release in January 2022, it is estimated that up to 7% of men are affected by infertility in the United Kingdom. Therefore the high prevalence of infertility is therefore expected to drive market growth due to the rise in the adoption of male fertility techniques.

Furthermore, rising technological advancements such as assisted reproductive technology have driven market growth further. Assisted reproductive technology is a medical procedure used to treat infertility that offers a quick fix to the male facing problems in infertility due to abnormal sperm quality, low sperm count, and poor motility. This procedure is being widely adopted due to its benefits, like a higher success rate compared to medications. For instance, according to the study published in the Journal of Urology in January 2021, addressing male infertility with specialized treatments and assisted reproductive methods is beneficial. Such studies show the importance of assisted reproductive methods in infertility testing, thereby leading to rising adoption and propelling the market growth.

Thus, the increasing population with infertility coupled with technological advancements in the field of assisted reproductive technologies results in promoting the revenue growth of the male infertility market.

However, the high cost of male infertility treatments is expected to impede market growth over the forecast period.

Male Infertility Industry Segmentation

As per the scope, male infertility is a type of health issue that lowers the chances of his female partner getting pregnant. It is majorly caused due to hormonal problems, low sperm count, and the presence of a low number of motile sperm. Male Infertility Market is segmented by Test Type (Sperm Agglutination, DNA Fragmentation Technique, Oxidative Stress Analysis, Computer Assisted Semen Analysis, Sperm Penetration Assay, and Others), Treatment (Medication and Assisted Reproductive Technology and Varicocele Surgery), Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Test Type
Sperm Agglutination
DNA Fragmentation Technique
Oxidative Stress Analysis
Computer Assisted Semen Analysis
Sperm Penetration Assay
Others
By Treatment
Medication
Assisted Reproductive Technology and Varicocele Surgery
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Male Infertility Market Size Summary

The male infertility market is poised for significant growth, driven by an increasing incidence of infertility and advancements in assisted reproductive technology (ART). The market's expansion is further fueled by rising awareness, lifestyle changes, and the high adoption of ART, which offers effective solutions for male infertility issues such as abnormal sperm quality and low sperm count. The COVID-19 pandemic has also played a role in market dynamics, as it highlighted the impact of viral infections on male fertility, leading to increased adoption of infertility testing. Despite the high cost of treatments posing a challenge, the market is expected to benefit from technological innovations and the growing prevalence of male infertility, which is a contributing factor in nearly half of reproductive issues globally.

North America is anticipated to lead the male infertility market, supported by a robust healthcare infrastructure and increased awareness. The region's growth is bolstered by initiatives from key market players and substantial funding for infertility research, which fosters the development of innovative testing methods. The DNA fragmentation testing segment is expected to experience notable growth due to its importance in assessing sperm health and the rise of at-home testing solutions. The market is characterized by fragmentation, with several major players actively contributing to its development through technological advancements and expanded service offerings. These factors collectively drive the market's trajectory, promising substantial growth in the coming years.

Explore More

Male Infertility Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing incidence of infertility

      2. 1.2.2 High Adoption of Assisted Reproductive Technology (ART)

      3. 1.2.3 Technological Advancements

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Treatment

    4. 1.4 Porter Five Forces

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Test Type

      1. 2.1.1 Sperm Agglutination

      2. 2.1.2 DNA Fragmentation Technique

      3. 2.1.3 Oxidative Stress Analysis

      4. 2.1.4 Computer Assisted Semen Analysis

      5. 2.1.5 Sperm Penetration Assay

      6. 2.1.6 Others

    2. 2.2 By Treatment

      1. 2.2.1 Medication

      2. 2.2.2 Assisted Reproductive Technology and Varicocele Surgery

    3. 2.3 Geography

      1. 2.3.1 North America

        1. 2.3.1.1 United States

        2. 2.3.1.2 Canada

        3. 2.3.1.3 Mexico

      2. 2.3.2 Europe

        1. 2.3.2.1 Germany

        2. 2.3.2.2 United Kingdom

        3. 2.3.2.3 France

        4. 2.3.2.4 Italy

        5. 2.3.2.5 Spain

        6. 2.3.2.6 Rest of Europe

      3. 2.3.3 Asia-Pacific

        1. 2.3.3.1 China

        2. 2.3.3.2 Japan

        3. 2.3.3.3 India

        4. 2.3.3.4 Australia

        5. 2.3.3.5 South Korea

        6. 2.3.3.6 Rest of Asia-Pacific

      4. 2.3.4 Middle-East and Africa

        1. 2.3.4.1 GCC

        2. 2.3.4.2 South Africa

        3. 2.3.4.3 Rest of Middle-East and Africa

      5. 2.3.5 South America

        1. 2.3.5.1 Brazil

        2. 2.3.5.2 Argentina

        3. 2.3.5.3 Rest of South America

Male Infertility Market Size FAQs

The Male Infertility Market size is expected to reach USD 3.85 billion in 2024 and grow at a CAGR of 3.54% to reach USD 4.58 billion by 2029.

In 2024, the Male Infertility Market size is expected to reach USD 3.85 billion.

Male Infertility Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)